18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.
about
Strategies for modern biomarker and drug development in oncology.PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical ProblemsMolecular imaging for early prediction of response to Sorafenib treatment in sarcoma.Trabectedin in the neoadjuvant treatment of high-grade pleomorphic sarcoma: report of a rare case and literature review.The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors.Evolving role of positron emission tomography (PET) in urological malignancy.Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma.Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.Biosynthesized Gold Nanoclusters and Iron Complexes as Scaffolds for Multimodal Cancer Bioimaging.Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.Extraskeletal osteosarcoma with synchronous regional lymph node and soft tissue metastasis: a rare presentation of an uncommon tumour.Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304
P2860
Q30590270-EC37F0CB-F088-4F3D-A4C5-7140C386FE21Q33356327-998EFB7E-2196-4D51-8D7C-C4B069BF402CQ37402623-D2444D25-3867-41FA-AC9D-CE89A124826EQ38080848-1F9EEB57-3488-4EE8-9414-A886ACF725D4Q38202025-7B21B591-4FD5-4911-B00E-DCCC8A97CDFBQ38269763-7BE21285-CFDF-4403-A30E-ACE1975F7A3AQ38412275-53991B12-F330-4E51-A6F5-7555FA459894Q38752259-C49F2D9B-E5F1-45BB-8CE3-993D89053732Q38817346-769BE486-DD1F-406E-BDFE-1C4509BC1EF1Q38840133-0A97CE60-21A8-43B8-8C5E-5EB31768E2C1Q39251874-CB931695-7D8E-43BE-87CC-845D0C90E28AQ44712017-23B58AA5-2B53-43E5-86FD-D187ADF25A78Q47111053-6598D3C7-1650-4C89-B193-540F49692977Q58790735-B02744A4-B37A-41FD-A11C-FBD35B2F3835
P2860
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@ast
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@en
type
label
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@ast
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@en
prefLabel
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@ast
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@en
P2093
P2860
P1476
18F-FDG-PET/CT Imaging as an e ...... ndergoing neoadjuvant therapy.
@en
P2093
Fritz C Eilber
Jeff J Eckardt
Johannes Czernin
Ken Herrmann
Martin S Allen-Auerbach
Matthias R Benz
Michael E Phelps
Sarah M Dry
Tibor Schuster
William D Tap
P2860
P304
P356
10.1158/1078-0432.CCR-11-2139
P407
P577
2012-02-14T00:00:00Z